Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT00594074 Terminated - Clinical trials for Obesity, Weight Loss, Alcohol Drinking

Alcohol in the Treatment of Obesity

Start date: April 2007
Phase: N/A
Study type: Interventional

This pilot study looks at the relationship of moderate alcohol consumption on weight loss.

NCT ID: NCT00594009 Terminated - Clinical trials for Pulmonary Disease, Chronic Obstructive

Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure

VVCO2R
Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study to determine the safety and effectiveness of a mechanical device to remove carbon dioxide from the blood of patients with chronic obstructive pulmonary disease (COPD)when they are hospitalized in the intensive care unit for exacerbation of their condition.

NCT ID: NCT00593229 Terminated - Clinical trials for Thrombotic Thrombocytopenic Purpura

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

Start date: January 2007
Phase: N/A
Study type: Observational

This registry will collect clinical data and store biosamples (seru, plasma, urine, and DNA) annually from pediatric patients with thrombotic mcroangiopathy

NCT ID: NCT00592228 Terminated - Clinical trials for Coronary Angiography

Proper Fractional Flow Reserve Criteria for Intermediate Lesions in the Era of Drug-eluting Stent

DEFER-DES
Start date: January 2007
Phase: N/A
Study type: Interventional

Angiographic evaluation for intermediate lesions is not always accurate. Fractional flow reserve-guided deferral strategy for these lesions showed the same event rate as routine intervention strategy. However, proper FFR criterion for these lesions in the era of drug-eluting stent is not known. This study sought to evaluate the clinical outcomes of intermediate lesions according to FFR and compare those of FFR-guided intervention with routine drug-eluting stent implantation strategy.

NCT ID: NCT00591474 Terminated - Clinical trials for GI Colonization of Vancomycin-resistant Enterococcus

The Influence of Probiotics on Vancomycin-Resistant Enterococcus

Start date: December 2007
Phase: N/A
Study type: Interventional

Drinking probiotics in a the form of a yogurt drink will restore normal gastrointestinal (GI) bacteria in patients whose colon are colonized with vancomycin-resistant enterococcus (VRE).

NCT ID: NCT00589329 Terminated - Clinical trials for Length of Pregnancy Prolongation in Hours

Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam

Start date: December 2007
Phase: N/A
Study type: Interventional

Preterm birth remains a major health concern affecting up to 12% of all live births prior to 37 weeks gestation. As preterm birth can often be associated with infection our proposal is to evaluate in a randomized fashion antibiotics for women with advanced cervical exams.

NCT ID: NCT00589316 Terminated - Clinical trials for Chronic Myelomonocytic Leukemia

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Start date: October 5, 2007
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of iodine I 131monoclonal antibody BC8 when given together with fludarabine phosphate, cyclophosphamide, total-body irradiation, and donor bone marrow transplant, and to see how well they work in treating patients with acute myeloid leukemia or acute lymphoblastic leukemia that has spread to nearby or other places in the body (advanced), or high-risk myelodysplastic syndrome. Giving chemotherapy drugs, such as fludarabine phosphate and cyclophosphamide, and total-body irradiation before a donor bone marrow transplant helps stop the growth of cancer or abnormal cells and helps stop the patient's immune system from rejecting the donor's stem cells. Also, radiolabeled monoclonal antibodies, such as iodine I 131 monoclonal antibody BC8, can find cancer cells and carry cancer-killing substances to them without harming normal cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Giving cyclophosphamide together with mycophenolate mofetil and tacrolimus after the transplant may stop this from happening. Giving a radiolabeled monoclonal antibody together with donor stem cell transplant, fludarabine phosphate, cyclophosphamide, mycophenolate mofetil, and tacrolimus may be an effective treatment for advanced acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndromes.

NCT ID: NCT00588354 Terminated - Clinical trials for Lumbar and Other Intervertebral Disc Disorders With Radiculopathy

Epidural Clonidine for Lumbosacral Radiculopathy

Start date: October 2006
Phase: N/A
Study type: Interventional

This was a randomized, blinded study of transforaminal epidural injection of clonidine versus a similar injection of corticosteroid for acute lumbosacral radiculopathy. The hypothesis was that clonidine will be as effective as steroid for this condition.

NCT ID: NCT00587223 Terminated - Clinical trials for Epidermolysis Bullosa Dystrophica

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the use of Apligraf for the treatment of nonhealing wounds in subjects with dystrophic or junctional epidermolysis bullosa. Apligraf will be evaluated for efficacy and safety compared to a conventional nonadherent dressing. A matched-pair design will be used to evaluate Apligraf treatment versus conventional treatment in 68 study pairs.

NCT ID: NCT00586794 Terminated - Clinical trials for Pulmonary Arterial Hypertension (PAH)

Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients

Start date: December 2007
Phase: Phase 3
Study type: Interventional

Eisenmenger's syndrome presents as a severe clinical picture of polymorbidity that constitutes a great burden at the individual as well as the familial and social level. The combination of critically increased pulmonary vascular resistance, progressive pressure load of the right ventricle and disturbance of pulmonary gas exchange result in long-term polymorbidity. The objective of this study is to provide evidence of improvement of patients exercise tolerance as well as general conditions by treatment with oral sildenafil as a specific pulmonary vasodilator.